Vivoryon (VVY) | Stock Overview & Key Data
Vivoryon Therapeutics N.V. | Small-cap | Healthcare
Vivoryon Therapeutics N.V. | Small-cap | Healthcare
Vivoryon Performance Comparison
Stock Range
Today's Range
Low: €1.43
High: €1.44
on August 8, 2025
52 Week Range
Low: €1.37
High: €2.99
on July 14, 2025
on September 30, 2024
All-Time High: €27.19 on January 11, 2016
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Market Cap
€36.9M
EPS
-0.79
P/E Ratio (TTM)
-1.77
Forward P/E
-1.86
P/B Ratio
4.63
PEG Ratio
-1.86
Div. Yield
N/A
ROE
-120.41%
Beta
1.957
Debt to Equity
1.29
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
0.00%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-62.22%
Return on Equity (TTM)
-120.41%
EBITDA
€-20.9M
Net Income (TTM)
€-20.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
N/A
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Vivoryon VVY | 36.91M Small-cap | 2.86% | -1.37% | -18.18% | -26.15% | -31.43% | -32.08% | -82.04% | -73.18% |
| Galapagos NV GLPGA | 1.88B Large-cap | -0.28% | 13.36% | 24.11% | 27.74% | 1.97% | 21.85% | -47.55% | -82.27% |
| Pharming Group N.V PHARM | 720.78M Mid-cap | 9.68% | 15.91% | 14.61% | 22.89% | 6.25% | 41.67% | 0.00% | -6.42% |
| Koninklijke Philips PHIA | 21.71B Large-cap | 0.70% | 11.60% | 7.33% | -14.05% | -6.08% | -12.55% | 18.37% | -48.02% |
| Renewi Plc RWI | 830.45M Small-cap | 0.39% | 1.58% | 1.38% | 5.53% | 6.30% | 31.71% | 23.95% | 244.48% |
| Amina Polkadot ETP SDOT | 146.73M Small-cap | 0.00% | 0.00% | 18.75% | 9.09% | 9.09% | -21.65% | 2.47% | -45.71% |
Ownership & Short Interest
Insider Ownership
24.84%
Institutional Ownership
6.80%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
26K
Average 90-Day Volume
39K
Vivoryon Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Vivoryon would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VVY's 52-week high and low?
- In the last 52 weeks, Vivoryon reached a high of €2.99 (on September 30, 2024) and a low of €1.37 (on July 14, 2025).
- What is the market cap and P/E ratio for VVY?
- Curious about Vivoryon's size and valuation? Its market capitalization stands at 36.91M. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.77, and the forward P/E (looking ahead) is -1.86.
- Does VVY pay dividends? If so, what's the yield?
- As for dividends, Vivoryon isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Vivoryon's main competitors or similar companies to consider before investing?
When looking at Vivoryon, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Galapagos NV
GLPGA1.88B Healthcare Biotechnology 21.85% -47.55% Pharming Group N.V
PHARM720.78M Healthcare Biotechnology 41.67% 0.00% Koninklijke Philips
PHIA21.71B Healthcare Medical Devices -12.55% 18.37% Renewi Plc
RWI830.45M Industrials Waste Management 31.71% 23.95% Amina Polkadot ETP
SDOT146.73M Consumer Defensive Farm Products -21.65% 2.47% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vivoryon Therapeutics N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Vivoryon's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -120.41%, the Debt to Equity ratio from the most recent quarter is 1.29, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for VVY?
- Looking at Vivoryon's growth, its revenue over the trailing twelve months (TTM) was €0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of VVY stock is held by insiders and institutions?
- Wondering who owns Vivoryon stock? Company insiders (like executives and directors) hold about 24.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 6.80%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.